CEFIXIME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefixime, and what generic alternatives are available?
Cefixime is a drug marketed by Alkem Labs Ltd, Aurobindo Pharma Ltd, Belcher, and Chartwell Rx. and is included in six NDAs.
The generic ingredient in CEFIXIME is cefixime. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefixime profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefixime
A generic version of CEFIXIME was approved as cefixime by AUROBINDO PHARMA LTD on April 14th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFIXIME?
- What are the global sales for CEFIXIME?
- What is Average Wholesale Price for CEFIXIME?
Summary for CEFIXIME
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 35 |
| Patent Applications: | 4,702 |
| Drug Prices: | Drug price information for CEFIXIME |
| What excipients (inactive ingredients) are in CEFIXIME? | CEFIXIME excipients list |
| DailyMed Link: | CEFIXIME at DailyMed |
Recent Clinical Trials for CEFIXIME
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of North Carolina, Chapel Hill | Phase 2 |
| Haiphong University of Medicine and Pharmacy | Phase 2 |
| Universidad Peruana Cayetano Heredia | Phase 3 |
Pharmacology for CEFIXIME
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFIXIME
Anatomical Therapeutic Chemical (ATC) Classes for CEFIXIME
US Patents and Regulatory Information for CEFIXIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | CEFIXIME | cefixime | CAPSULE;ORAL | 210574-001 | Oct 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Belcher | CEFIXIME | cefixime | FOR SUSPENSION;ORAL | 206938-002 | Feb 6, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Ltd | CEFIXIME | cefixime | FOR SUSPENSION;ORAL | 204835-001 | Apr 14, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Belcher | CEFIXIME | cefixime | FOR SUSPENSION;ORAL | 206939-001 | Feb 6, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
